Affidea Romania SRL

Bucharest 022328

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma, Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV

Studies at this site

• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed